These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Gene therapy for color blindness. Bennett J N Engl J Med; 2009 Dec; 361(25):2483-4. PubMed ID: 20018970 [No Abstract] [Full Text] [Related]
3. [Dogs recover their sight thanks to viral vectors that could be used in humans]. Casselyn M Rev Med Suisse; 2006 Oct; 2(84):2444. PubMed ID: 17121256 [No Abstract] [Full Text] [Related]
4. [Corrective therapy for color blindness with the help of colored contact lenses?]. Krastel H; Castro A Klin Monbl Augenheilkd; 1999 Feb; 214(2):aA8-10. PubMed ID: 10218193 [No Abstract] [Full Text] [Related]
5. Physiology of color vision and the pathological changes in reversible color blindness, a deficiency disease of the retina. Raymond LF Ann Ophthalmol; 1975 Apr; 7(4):532-4. PubMed ID: 1080032 [No Abstract] [Full Text] [Related]
7. Note on Dunlap's remedy for defective color vision. ELDER JH Psychol Bull; 1946 Jan; 43():77-9. PubMed ID: 21012630 [No Abstract] [Full Text] [Related]
8. Day blind sheep and the importance of large animal disease models. Komáromy AM Vet J; 2010 Sep; 185(3):241-2. PubMed ID: 20061167 [No Abstract] [Full Text] [Related]
9. Prospects for retinal gene replacement therapy. Smith AJ; Bainbridge JW; Ali RR Trends Genet; 2009 Apr; 25(4):156-65. PubMed ID: 19303164 [TBL] [Abstract][Full Text] [Related]
10. Report on the effect of training in color blindness. McCORD F J Clin Psychol; 1947 Apr; 3(2):197. PubMed ID: 20239993 [No Abstract] [Full Text] [Related]
11. Effect of vitamin A administration upon defective color vision. RICHARDSON JA; KINARD FW South Med J; 1946 Oct; 39():811-3. PubMed ID: 20997517 [No Abstract] [Full Text] [Related]
12. Von Senden, Mesmer, and the recovery of sight in the blind. Forrest DW Am J Psychol; 1974 Dec; 87(4):719-22. PubMed ID: 4463730 [No Abstract] [Full Text] [Related]
13. Low-dose busulphan conditioning and neonatal stem cell transplantation preserves vision and restores hematopoiesis in severe murine osteopetrosis. Askmyr M; Holmberg J; Flores C; Ehinger M; Hjalt T; Richter J Exp Hematol; 2009 Feb; 37(2):302-8. PubMed ID: 19100677 [TBL] [Abstract][Full Text] [Related]
14. [The inhibition of the c-Myc gene: a step toward an almost universal therapy of cancer?]. Larsen CJ Bull Cancer; 2008 Sep; 95(9):797-8. PubMed ID: 18837148 [No Abstract] [Full Text] [Related]
15. Comparison of toxicogenomic profiles of two murine strains treated with HIV-1-based vectors for gene therapy. Zhao Y; Keating K; Thorpe R Toxicol Appl Pharmacol; 2007 Dec; 225(2):189-97. PubMed ID: 17904176 [TBL] [Abstract][Full Text] [Related]
16. The use of tinted contact lenses in the management of achromatopsia. Zeltzer HI Optometry; 2007 Jul; 78(7):328. PubMed ID: 17601566 [No Abstract] [Full Text] [Related]
18. [First results of gene therapy for Leber congenital amaurosis]. Nau JY Rev Med Suisse; 2008 May; 4(156):1177. PubMed ID: 18630174 [No Abstract] [Full Text] [Related]
19. Hydrodynamic delivery of siRNA in a mouse model of sepsis. Wesche-Soldato DE; Lomas-Neira J; Perl M; Chung CS; Ayala A Methods Mol Biol; 2008; 442():67-73. PubMed ID: 18369778 [TBL] [Abstract][Full Text] [Related]
20. Preclinical development of T cell receptor gene therapy. Bendle GM; Haanen JB; Schumacher TN Curr Opin Immunol; 2009 Apr; 21(2):209-14. PubMed ID: 19321326 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]